Analysts Offer Insights on Financial Companies: Synovus (NYSE: SNV), WashingtonFirst Bankshares (NASDAQ: WFBI) and Metlife (NYSE: MET)

By Austin Angelo

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Synovus (NYSE: SNV), WashingtonFirst Bankshares (NASDAQ: WFBI) and Metlife (NYSE: MET).

Synovus (NYSE: SNV)

KBW analyst Brady Gailey reiterated a Hold rating on Synovus (NYSE: SNV) yesterday and set a price target of $43. The company’s shares closed yesterday at $41.22.

According to TipRanks.com, Gailey is a 5-star analyst with an average return of 13.1% and a 77.2% success rate. Gailey covers the Financial sector, focusing on stocks such as Atlantic Capital Bancshares, First Financial Bankshares, and Allegiance Bancshares Inc.

Currently, the analyst consensus on Synovus is Hold and the average price target is $44.67, representing an 8.4% upside.

In a report issued on May 5, Jefferies also reiterated a Hold rating on the stock with a $47 price target.
WashingtonFirst Bankshares (NASDAQ: WFBI)

KBW analyst Catherine Mealor reiterated a Hold rating on WashingtonFirst Bankshares (NASDAQ: WFBI) yesterday and set a price target of $38. The company’s shares closed yesterday at $33.79, close to its 52-week high of $36.16.

According to TipRanks.com, Mealor is a 5-star analyst with an average return of 15.1% and a 76.0% success rate. Mealor covers the Financial sector, focusing on stocks such as Union First Market Bankshares Corp, American National Bankshares, and Community Bankers Trust Corp.

WashingtonFirst Bankshares has an analyst consensus of Hold, with a price target consensus of $38.

Metlife (NYSE: MET)

In a report released yesterday, Ryan Krueger from KBW reiterated a Buy rating on Metlife (NYSE: MET), with a price target of $59. The company’s shares closed yesterday at $50.48.

According to TipRanks.com, Krueger is a 5-star analyst with an average return of 14.0% and a 70.6% success rate. Krueger covers the Financial sector, focusing on stocks such as Prudential Financial Inc, Lincoln National Corp, and Ameriprise Financial.

Currently, the analyst consensus on Metlife is Moderate Buy and the average price target is $59.40, representing a 17.7% upside.

In a report issued on May 4, Wells Fargo also reiterated a Buy rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.